AACHEN, Germany and TORONTO, Feb. 24, 2025 /PRNewswire/ -- Grünenthal, a global leader in pain management and related diseases, and Apotex Inc. ("Apotex"), the largest Canadian-based ...

AACHEN, Germany and TORONTO, Feb. 24, 2025 /PRNewswire/ -- Grünenthal, a global leader in pain management and related diseases, and Apotex Inc. ("Apotex"), the largest Canadian-based pharmaceutical ...

We describe pronounced hypotension in a patient during orthostatic testing while receiving treatment with sildenafil and tamsulosin, but not with placebo. The patient was 71 years of age and had ...

The Symptom Management After Reducing Therapy (SMART-1) trial examined the combination of dutasteride and tamsulosin, followed by withdrawal of tamsulosin in symptomatic men. [9] This trial ...

TORONTO and AACHEN, Germany, Feb. 24, 2025 /PRNewswire/ - Apotex Inc. (“Apotex”), the largest Canadian-based pharmaceutical company, and Grünenthal, a global leader in pain management and related ...